XLO 10-Q: SEC filing
Xilio Therapeutics
Filed with the SEC on · accession 0001193125-26-454453
XLO filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -2.2% by the first close after the filing.
Summary of the filing
Xilio Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing ongoing collaboration and license agreements with Gilead Sciences and AbbVie, along with various equity financings including follow-on offerings and at-the-market sales.
Key details
How XLO stock reacted
Close before
$9.00
Nov 9, 2026
First close after
-2.22%
$8.80
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for XLO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for XLO?
Click hereFrequently asked questions
What did XLO file with the SEC on Nov 10, 2026?
XLO filed a 10-Q (SEC filing). Xilio Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing ongoing collaboration and license agreements with Gilead Sciences and AbbVie, along with various equity financings including follow-on offerings and at-the-market sales.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did XLO stock react to this filing?
XLO closed at $9.00 before the filing and $8.80 on Nov 10, 2026 (-2.22%).
Other XLO SEC filings
- 8-K · SEC filingNov 10, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 12, 2026
- 8-K · SEC filingJun 12, 2026
- S-3/A · Shelf registrationMay 27, 2026
- S-3 · Shelf registrationMay 12, 2026
- 8-K · SEC filingMay 12, 2026
- 10-Q · SEC filingMay 12, 2026
- DEF 14A · Board changeApr 28, 2026
Get alerts when XLO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days